Click to search

Safety and efficacy of tazarotene foam for the treatment of acne vulgaris.

Epstein EL, et al. Clin Cosmet Investig Dermatol. 2013.

Abstract

BACKGROUND: Tazarotene foam is the first topical retinoid foam approved for the treatment of acne vulgaris.

OBJECTIVE: To review the safety and efficacy studies of tazarotene foam in the treatment of moderate to severe acne.

METHODS: Five Phase I safety studies in normal controls are reviewed and two Phase III safety and efficacy studies in patients with moderate to severe acne are reviewed.

CONCLUSION: Tazarotene foam, 0.1% was effective in the treatment of moderate to severe acne vulgaris with an acceptable tolerability profile. This treatment provides a cosmetically favorable alternative for topical retinoid therapy.

PMID

23696711 [PubMed]

PMCID

PMC3658431

Full text

 Citation 3 of 101 Back to results 

Similar articles

See all